SCHEMBL17853517

SCHEMBL17853517

c1ccc(-c2nc(-c3ccc(-c4ccncc4)cc3)cc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.44
▸ ATM Q13315 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ KMT2A Q03164 8/20 0.41
▸ MAPT P10636 8/20 0.41
▸ MEN1 O00255 7/20 0.41
▸ DHODH Q02127 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ HPGD P15428 4/20 0.41
▸ NTSR1 P30989 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ PTGER4 P35408 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853526 0.98 KDM4E (0.44) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL17853549 0.96 KDM4E (0.43) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL24590281 0.95 MAPT (0.45) KDM4EKMT2AMAPTMEN1DHODH
SCHEMBL19486679 0.94 KDM4E (0.41) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL23085190 0.94 KDM4E (0.45) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL17853567 0.92 MAPT (0.45) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL17853562 0.92 MAPT (0.45) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL19397645 0.92 MAPT (0.45) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL17853489 0.92 MAPT (0.45) KDM4EATML3MBTL1KMT2AMAPT
SCHEMBL19397642 0.92 MAPT (0.45) KDM4EATML3MBTL1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, SLC39A11 KDM4E 2180/4885ATM 3426/4885L3MBTL1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback